Who needs bleomycin in classic Hodgkin lymphoma? Comment on: "Bleomycin omission in limited-stage classic Hodgkin lymphoma with negative PET scan after two cycles of ABVD".
- DOI
- 10.3324/haematol.2026.301946
- Published
- 2026 Sep 24
- Container
- Haematologica
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3324/haematol.2026.301946,
title = {Who needs bleomycin in classic Hodgkin lymphoma? Comment on: "Bleomycin omission in limited-stage classic Hodgkin lymphoma with negative PET scan after two cycles of ABVD".},
author = {Vincenzi A and Picardi M},
year = {2026},
journal = {Haematologica},
doi = {10.3324/haematol.2026.301946},
url = {https://doi.org/10.3324/haematol.2026.301946}
}RIS
TY - JOUR TI - Who needs bleomycin in classic Hodgkin lymphoma? Comment on: "Bleomycin omission in limited-stage classic Hodgkin lymphoma with negative PET scan after two cycles of ABVD". AU - Vincenzi A AU - Picardi M PY - 2026 JO - Haematologica DO - 10.3324/haematol.2026.301946 UR - https://doi.org/10.3324/haematol.2026.301946 ER -
APA
A, V., & M, P. (2026). Who needs bleomycin in classic Hodgkin lymphoma? Comment on: "Bleomycin omission in limited-stage classic Hodgkin lymphoma with negative PET scan after two cycles of ABVD".. Haematologica. https://doi.org/10.3324/haematol.2026.301946
Source records
- pubmed · retrieved 2026-09-26T00:21:44.452Z